Stemina Prepares for Commercialization
Stemina Biomarker Discovery is preparing to go to market in early 2018 with its autism diagnostic test panel, the company announced recently. According to a release, Heiner Dreismann, the former head…
Category Archives: Biotech
JangoBio Adding Staff, Expanding Testing Capabilities
Story provided by Alex Moe, WisBusiness.com A Madison-based biotech startup with ambitious goals is adding staff and expanding testing capabilities as it seeks early-stage investment. JangoBio is trying to develop…
Propeller, GSK Expand Collaboration
Propeller Health has extended its 2015 collaboration with GlaxoSmithKline (GSK) to improve management of asthma and COPD, the company announced recently. “We are excited to be working closely with GSK…
Cellectar’s Platform Shows Therapeutic Potential
Cellectar Biosciences‘ Phospholipid Drug Conjugate (PDC) research program has generated numerous PDC molecules that show “significant” improved pharmacologic activity, the company announced today. According to a release, Cellectar’s research demonstrates that…
Cellectar Provides Myeloma Study Update
Cellectar Biosciences’ CLR 131 has achieved an overall survival of greater than 22 months in advanced multiple myeloma patients, the company announced today. “We continue to make meaningful progress on…
SHINE Breaks Ground in Janesville
SHINE Medical Technologies broke ground today on Building One, its nuclear technology facility in Janesville, Wis. The 11,500-square-foot facility, located east of Southern Wisconsin Regional Airport, will house a prototype to…
MVI Provides Trial Update
In its clinical trial to treat prostate cancer, Madison Vaccines Incorporated (MVI) announced today it has begun dosing 20 patients. According to a release, MVI is exploring the use of its gene…
Cellectar Announces Swiss Collaboration
Cellectar Biosciences announced today that it will collaborate with Avicenna Oncology, a clinical stage biotechnology company based in Switzerland, to develop new phospholipid drug conjugates for solid tumors. According to…
Invenra, Merck to Collaborate
Invenra will collaborate with Merck, a pharmaceutical company, to discover fully human therapeutic antibodies against an unnamed target of interest to Merck, the company announced recently. “We are excited to…
Exact Sciences Releases 2Q Stats
Exact Sciences recently announced its second quarter numbers, which included revenue of $57.6 million and 135,000 completed Cologuard tests, an increase of 172 percent and 149 percent, respectively. “As patient and…
